Consumer Health in Colombia

Growth remains strong, but limited by contraband
Growth in consumer health remained strong in 2011, just slightly higher than the growth rate seen in 2010. Growth was fuelled by bad weather, but also by the continued growth of the economy and disposable incomes in general. However, contraband sales continued to limit growth. The regulatory agency INVIMA reacted with more inspections of retail outlets and greater communication about which products are not authorised to be sold in Colombia.

Bad weather boosts demand
Global warming and the climate phenomena El Niño and La Niña deteriorated the health of the population. The development of a viral flu accompanied by gastrointestinal complaints repeatedly affected much of the population, increasing their consumption of analgesics, cough, cold and allergy (hay fever) remedies and digestive remedies.

GlaxoSmithKline de Colombia maintains the lead in consumer health
GlaxoSmithKline de Colombia remained the leading company in consumer health in 2011. The brand Dolex achieved the leading position through strong advertising, and its success was also due to having different presentations adapted to different buyers’ financial capacity. Tecnoquímicas remained in second position, but saw strong growth in 2011 as a result of strategies developed specifically to take share from the brands Dolex and Advil. Its strategy was to develop packaging with similar characteristics, with mass media advertising and cheaper prices.

Healthfood shops see an increase in share
Parapharmacies/drugstores is losing share to the growing number of healthfood shops and larger drug shelves in supermarkets. Distribution channels compete with strategies such as customer loyalty through the web, and exclusive benefits for members in stores. Locatel opened 11 new stores in the country, and Farmatodo was one of the most active companies in the network, with 32,000 followers on Twitter.

Get Your Copy of Report @ http://www.reportsnreports.com/reports/160655-consumer-health-in-colombia.html  

Report Details :
Published: May 2012
Price: US $2400

    

Table of Contents
Consumer Health in Colombia - Industry Overview
EXECUTIVE SUMMARY
Growth remains strong, but limited by contraband
Bad weather boosts demand
GlaxoSmithKline de Colombia maintains the lead in consumer health
Healthfood shops see an increase in share
Price control could limit forecast growth
KEY TRENDS AND DEVELOPMENTS
Overweight and obese population increasing
High levels of stress are felt in large cities
Self-medication is a popular practice in Colombia
Colombian government commits to biotechnological development
Demographic changes impact consumer health
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 2 Life Expectancy at Birth 2006-2011
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2006-2011
Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 5 Consumer Health Company Shares 2007-2011
Table 6 Consumer Health Brand Shares 2008-2011
Table 7 Penetration of Private Label by Category 2006-2011
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 10 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
OTC registration and classification
Delisting or de-reimbursement
Advertising
Packaging and Labelling
Distribution
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventative medicine
Switches
Summary 1 OTC Switches 2009-2011
  

Consumer Health in New Zealand

The Consumer Health in New Zealand market research report includes:

• Analysis of key supply-side and demand trends
• Detailed segmentation of international and local products
• Historic volumes and values, company and brand market shares
• Five year forecasts of market trends and market growth 
• Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

• What is the market size of Consumer Health in New Zealand?
• What are the major brands in New Zealand?
• What are the main trends in OTC Healthcare?

New Zealand Consumer Health Industry

Published: March 2012
Price: Single User License: US$ 2400

 
Few points from Table of Content Consumer Health in New Zealand - Industry Overview
EXECUTIVE SUMMARY
MARKET DATA
Table 1 Penetration of Private Label by Sector 2006-2011
Consumer Health in New Zealand - Industry Context
EXECUTIVE SUMMARY
Consumer health remains buoyant during 2011
Prevention remains a major focus area
Vitaco Health continues to lead sales
Direct selling channel records growth in 2011
Value sales expected to increase over forecast period
KEY TRENDS AND DEVELOPMENTS
New Zealand’s ageing population
New Zealand to be smoke-free by 2025
Natural health products bill
Christchurch earthquake
Natural healing and prevention
MARKET INDICATORS
Table 2 Consumer Expenditure on Health Goods and Medical Services 2006-2011
Table 3 Life Expectancy at Birth 2006-2011
MARKET DATA
Table 4 Sales of Consumer Health by Category: Value 2006-2011
Table 5 Sales of Consumer Health by Category: % Value Growth 2006-2011
Table 6 Consumer Health Company Shares 2007-2011
Table 7 Consumer Health Brand Shares 2008-2011
Table 8 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
Table 9 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
Table 10 Forecast Sales of Consumer Health by Category: Value 2011-2016
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventative medicine
Switches
Summary 1 OTC - Switches 2009-2011
DEFINITIONS
SOURCES
Summary 2 Research Sources
Consumer Health in New Zealand - Company Profiles
Douglas Pharmaceuticals Ltd in Consumer Health (New Zealand)
STRATEGIC DIRECTION
KEY FACTS
COMPANY BACKGROUND
PRODUCTION
COMPETITIVE POSITIONING
Summary 4 Douglas Pharmaceuticals: Competitive Position 2011

Consumer Health in Israel

Slower growth for consumer health in 2011

During 2011, the consumer health market showed slower growth than was seen over the review period. The slower growth was due to rising regulatory involvement within the consumer health category, which led many players to invest in products outside of the category, such as medical devices, cosmetics and vitamins and dietary supplements (VDS). As a result, the VDS category attracted new players which in turn increased competition, drove prices down and thus also slowed growth of the overall category.

The government becomes more proactive in public health issues

In 2011, the Israeli government took a more proactive stance against addiction related issues. Within consumer health care this concern manifested in regulations on products that, when abused, can damage the health. For example, oral decongestants became regulated in an effort to alert the public to the damages of long-term use of these products. Laxatives were switched to Rx status in response to young Israeli women abusing these products for the purpose of losing weight. Another regulatory action by the government was an attempt to regulate the prices of all consumer health products.

New key product categories increase competition and push prices down

As VDS products are relatively easier than consumer health to produce and to import, and their prices are not regulated, the VDS category in Israel is more attractive to companies in which to launch new products. In 2011 there was increased competition within categories such as omega 3-6-9 and glucosamine. New players, previously specialising in consumer health, entered those categories in search of larger profit margins. The growing competition in VDS caused a decrease in average unit price and a slowing of growth of the whole category.

Israel Consumer Health Market

Published: February 2012
No. of Pages: 290
Price : Single User License - US$2400



The Consumer Health in Israel market research report includes:

• Analysis of key supply-side and demand trends
• Detailed segmentation of international and local products
• Historic volumes and values, company and brand market shares
• Five year forecasts of market trends and market growth 
• Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

• What is the market size of Consumer Health in Israel?
• What are the major brands in Israel?
• What are the main trends in OTC Healthcare?

Why buy this report?

• Gain competitive intelligence about market leaders
• Track key industry trends, opportunities and threats
• Inform your marketing, brand, strategy and market development, sales and supply functions